Jonathan D. Schertzer

1200 Main St. W
Hamilton, ON L8N3Z5, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 108 publications

Statins promote muscle metabolic danger and NLRP3-mediated myopathy via lower protein-prenylation and YAP.

Statins promote muscle metabolic danger and NLRP3-mediated myopathy via lower protein-prenylation and YAP.

Journal: Science advances

Published: June 19, 2026

Immunometabolism of IRF4 in adipose, muscle, and immune cells influences obesity and MASLD.

Immunometabolism of IRF4 in adipose, muscle, and immune cells influences obesity and MASLD.

Journal: American journal of physiology. Endocrinology and metabolism

Published: March 09, 2026

Postbiotic gut bacteria site-specific immunomodulators improve liver steatosis, inflammation, and fibrosis in obese mice with MASLD.

Postbiotic gut bacteria site-specific immunomodulators improve liver steatosis, inflammation, and fibrosis in obese mice with MASLD.

Journal: American journal of physiology. Endocrinology and metabolism

Published: January 19, 2026

Postbiotic gut bacteria site-specific immunomodulators improve liver steatosis, inflammation, and fibrosis in obese mice with MASLD.

Postbiotic gut bacteria site-specific immunomodulators improve liver steatosis, inflammation, and fibrosis in obese mice with MASLD.

Journal: American journal of physiology. Endocrinology and metabolism

Published: January 19, 2026

Postbiotics lower adipose tissue MHCII inflammation and blood glucose in obese mice, dependent on sex.

Postbiotics lower adipose tissue MHCII inflammation and blood glucose in obese mice, dependent on sex.

Journal: Physiological reports

Published: January 09, 2026

Protocol for determining gut microbiota metabolites as substrates in mouse metabolism.

Protocol for determining gut microbiota metabolites as substrates in mouse metabolism.

Journal: STAR protocols

Published: October 16, 2025

Hyperglycemia worsens gut bacterial infection through intestinal Wnt, but independent of endotoxemia or obesity.

Hyperglycemia worsens gut bacterial infection through intestinal Wnt, but independent of endotoxemia or obesity.

Journal: American journal of physiology. Endocrinology and metabolism

Published: August 18, 2025

Insulin and adipocyte IRF4 promote fat retention over muscle preservation during intermittent fasting in obesity.

Insulin and adipocyte IRF4 promote fat retention over muscle preservation during intermittent fasting in obesity.

Journal: Cell reports

Published: August 08, 2025

NOD1 promotes leukocyte clearance and limits inflammation in female mice during obesity-associated acute lung injury.

NOD1 promotes leukocyte clearance and limits inflammation in female mice during obesity-associated acute lung injury.

Journal: Physiological reports

Published: May 31, 2025

Microbiota protect against frailty and loss of skeletal muscle, and maintain inflammatory tone during aging in mice.

Microbiota protect against frailty and loss of skeletal muscle, and maintain inflammatory tone during aging in mice.

Journal: American journal of physiology. Cell physiology

Published: February 10, 2025

Food supply toxicants and additives alter the gut microbiota and risk of metabolic disease.

Food supply toxicants and additives alter the gut microbiota and risk of metabolic disease.

Journal: American journal of physiology. Endocrinology and metabolism

Published: January 28, 2025

Not So Fast: Intermittent Fasting Fails to Improve Metabolic Flexibility in Mice With Obesity and Type 2 Diabetes.

Not So Fast: Intermittent Fasting Fails to Improve Metabolic Flexibility in Mice With Obesity and Type 2 Diabetes.

Journal: Physiology (Bethesda, Md.)

Published: December 24, 2024

Showing 1-12 of 108

Last Updated: 09/26/2026